.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...
.We already know that Takeda is actually wanting to discover a course to the FDA for epilepsy medici...
.Immunology biotech VBI Vaccines is veering dangerously near to the point of no return, with strateg...
.It's not easy to muscle mass in on a space as affordable as immunology, but Celldex Therapeutics be...
.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and also a preclinical i...
.Ventyx Biosciences' Crohn's disease medicine performed not aid clients achieve remission in a perio...
.Cognition Therapeutics' phase 2 sparkle trial has taken a number of the gloss off the Alzheimer's i...
.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, stopp...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers Squ...
.After connecting to much more than 200 business to partner a Tourette syndrome therapy that present...